This website is intended for healthcare professionals only

Trending Topic

16 mins

Trending Topic

Developed by Touch
Mark CompleteCompleted
BookmarkBookmarked

Hypertension is the leading modifiable risk factor for global cardiovascular disease, responsible for an estimated 10.8 million deaths and more than 200 million disability-adjusted life years annually.1 Despite the availability of effective pharmacological and lifestyle interventions, prevalence continues to rise, particularly in low- and middle-income countries (LMICs), where over three-quarters of all cases now occur.2 The condition’s […]

92/Long QT syndrome type 1 mutant channels reported to have blunted channel activation following sympathetic modulation have preserved responsiveness to adrenergic stimulation when recorded using perforated patch

2 mins
Share
Facebook
X (formerly Twitter)
LinkedIn
Via Email
Mark CompleteCompleted
BookmarkBookmarked
Copy LinkLink Copied
Published Online: Sep 27th 2010 European Journal of Arrhythmia & Electrophysiology. 2020;6(Suppl. 1):abstr92
Select a Section…
1

Article

Introduction: Long QT Syndrome type 1 (LQT1) is caused by mutations in KCNQ1. KCNQ1 co-assembles with KCNE1 to underlie the slow delayed rectifier potassium current (IKs). The relative contribution of IKs to ventricular repolarisation is thought to be greater during sympathetic activation. Beta-adrenergic receptor stimulation leads to activation of Protein Kinase A (PKA) and subsequent phosphorylation of KCNQ1, resulting in augmentation of IKs. The significance of sympathetic influence on channel activity is corroborated by the finding that patients with LQT1 have a high incidence of ventricular arrhythmias during exercise. Various LQT1 mutations have been reported to blunt sympathetic mediated augmentation of IKs and it is postulated that this plays a key role in disease pathogenesis. In general, the effects of sympathetic stimulation on the wild-type (WT) channel or LQT1 mutant channels have been assessed using the whole-cell patch clamp configuration, which has the disadvantage of disrupting the intracellular environment and intracellular signalling pathways. In this study, to overcome this problem, we determined the effects of beta-adrenergic stimulation on the WT channel or non-responsive LQT1 mutant channels using the perforated patch whole-cell (PPWC) configuration.

Methods: Site directed mutagenesis was used to generate mutant channels. To replicate previous studies, we mimicked patient phenotype by transfecting cells Human Embryonic Kidney-293 cells with WT and mutant KCNQ1 (with green fluorescent protein fused at the C-terminus) along with KCNE1 to create a heterozygous form (WT+mutant). Homozygous mutants were created by transfecting mutant KCNQ1 with KCNE1. Currents were recorded at room temperature using the PPWC configuration 48-72 hrs after transfection. Isoprenaline (ISO) (100 nM) was used to activate beta-adrenergic receptor

Results: First, we validated our system by determining channel responsiveness when key PKA phosphorylation sites were removed by mutation of serine residues (S27A) and (S92A). At +80 mV the WT channel had a significant 2.67-fold increase in current density after exposure to ISO. Both phosphorylation site mutants (when expressed in homozygous form individually or combined- S27A, S92A or S27A/S92A) prevented a statistically significant response to ISO. Next, we established the responsiveness of S27A/S92A+WT, or the previously reported non-responsive LQT1 mutations G269S+ WT, A341V+WT and V254M+WT, when expressed in heterozygous form. Upon exposure to ISO the mutant channels displayed significant 2.19, 2.50, 1.81 and 2.86-fold increments in current density (at +80 mV) respectively (Fig 1). Interestingly, the fold-change response to ISO was not significantly different between the WT channel and mutant channels.

Conclusion: Our data postulates that these mutations have preserved channel activation during sympathetic stimulation, hence highlighting the importance of using the PPWC configuration when investigating responsiveness to beta-adrenergic receptor stimulation.

 

2

Further Resources

Share
Facebook
X (formerly Twitter)
LinkedIn
Via Email
Mark CompleteCompleted
BookmarkBookmarked
Copy LinkLink Copied
Close Popup